收藏切换
Advances in the strategies of nasal into brain nanodelivery and the treatment of brain diseases
收藏切换
PDF
Peng XIAN1, Ling-hui ZOU1, Shu-ting NI2, *, Mei LIU3, *, Kai-li HU1, *
Acta Pharmaceutica Sinica | 2024, 59(12) : 3199 - 3214
Less
收藏切换
Acta Pharmaceutica Sinica | 2024, 59(12): 3199-3214
Advances in the strategies of nasal into brain nanodelivery and the treatment of brain diseases
Full
Peng XIAN1, Ling-hui ZOU1, Shu-ting NI2, *, Mei LIU3, *, Kai-li HU1, *
Affiliations
  • 1. School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
  • 2. Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
  • 3. Industrial Development Center of Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
Published: 2024-12-12 doi: 10.16438/j.0513-4870.2024-0656
Outline
收藏切换

The blood-brain barrier limits the brain delivery of most drugs and affects the treatment of central nervous system disorders. The transnasal drug delivery allows the drug to bypass the blood-brain barrier and reach the brain directly through pathways such as the olfactory and trigeminal nerves, thus improving the therapeutic efficacy of the drug while reducing drug degradation and avoiding hepatic first pass effect. With the rise of nanotechnology, the combination of nanoformulations with transnasal routes of administration is expected to achieve better brain targeting and treatment of brain diseases. On the basis of summarizing the characteristics of the various nose-to-brain pathways, this review summarizes the researches on novel transnasal nanopreparations such as exosomes and liquid crystals in recent years as well as new strategies to improve the efficiency of brain entry including focused ultrasound-mediated techniques. We also review the recent studies on transnasal brain entry nanopreparations in the treatment of various brain disorders and current research dilemmas, looking forward to the prospect of their future clinical applications.

intranasal administration  /  blood-brain barrier  /  brain targeting  /  nanoparticle delivery  /  brain disease
Peng XIAN, Ling-hui ZOU, Shu-ting NI, Mei LIU, Kai-li HU. Advances in the strategies of nasal into brain nanodelivery and the treatment of brain diseases[J]. Acta Pharmaceutica Sinica, 2024 , 59 (12) : 3199 -3214 . DOI: 10.16438/j.0513-4870.2024-0656
Year 2024 volume 59 Issue 12
PDF
192
81
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2024-0656
  • Receive Date:2024-07-12
  • Online Date:2025-11-24
  • Published:2024-12-12
Article Data
Affiliations
History
  • Received:2024-07-12
  • Revised:2024-09-13
Funding
Affiliations
    1. School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
    2. Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
    3. Industrial Development Center of Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2024-0656
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT